Lipocine provides new regulatory update on tlando™

Salt lake city, dec. 4, 2020 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the u.s. food and drug administration ("fda") has informed the company that it is continuing to work...
LPCN Ratings Summary
LPCN Quant Ranking